Competitive Technologies, Inc. has announced that patent number 6,808,561 has been issued by the US Patent Office for Dr. Brian R. Genge's nanotechnology bone biomaterial developed at the University of South Carolina (USC). CTT has an exclusive agreement with the University of South Carolina Research Foundation to license and commercialize the nanotechnology, an injectible calcium phosphate-based biomaterial.
Suzanne N. B. Alent, CTT's VP Marketing and Business Development said, "CTT has an agreement with a major dental products company to research the manufacture and use of this nanotechnology for dental applications. We will continue to aggressively market this superior technology for all aspects of its capabilities."
In addition to its use in the dental field, the patented nanotechnology can also be applied to a variety of human orthopaedic procedures, especially related to the spine and craniofacial reconstruction, as well as veterinary uses. The bone biomaterial technology is an easily flowable, mouldable paste that conforms to and interdigitates with the host bone. It rapidly hardens itself in vivo, forming a solid bone-like structure capable of stabilizing fractured bone within 15 minutes and supports the growth of cartilage and bone cells. The technology has superior compressive strength making it suitable for weight and non-weight bearing bones, and is both machinable and drillable, the official statement said.
Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions.